
- Pharmaceutical Executive-04-01-2001
- Volume 0
- Issue 0
Liberated?
Patents before profits. That soundbite snagged my ears and turned my full attention to the CNN business report. I recognized the voice and the face}Ray Gilmartin, chairman of Merck. Calmly and reasonably, he explained how extraordinary circumstances in the developing world demand that his company uncouple the normally fused objectives of high profitability and unwavering patent protection.
Articles in this issue
over 24 years ago
Internet DTC - Minding Your P's & Q'sover 24 years ago
Regulation: Two-Track Planover 24 years ago
Policy: Tectonic Shiftover 24 years ago
A Matter of Tasteover 24 years ago
Partnerships: Bargaining Biotechsover 24 years ago
Pediatric Mandateover 24 years ago
Genentech's Passion for Patientsover 24 years ago
Regulation: OK After AllNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.





